Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNG2 | P59768 | 9/20 | 1.00 |
| ▸ | GNB1 | P62873 | 9/20 | 1.00 |
| ▸ | KDM4A | O75164 | 1/20 | 0.57 |
| ▸ | USP2 | O75604 | 1/20 | 0.57 |
| ▸ | NSD2 | O96028 | 1/20 | 0.57 |
| ▸ | ALPL | P05186 | 1/20 | 0.57 |
| ▸ | PLCG1 | P19174 | 1/20 | 0.57 |
| ▸ | TNNI3 | P19429 | 1/20 | 0.57 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.57 |
| ▸ | TNNT2 | P45379 | 1/20 | 0.57 |
| ▸ | MMP14 | P50281 | 1/20 | 0.57 |
| ▸ | CASP6 | P55212 | 1/20 | 0.57 |
| ▸ | TNNC1 | P63316 | 1/20 | 0.57 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.49 |
| ▸ | HPGD | P15428 | 5/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 5/20 | 0.49 |
| ▸ | HSPA1A | P0DMV8 | 4/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2777300 | 0.88 | GNG2 (1.00) | GNG2GNB1KDM4AUSP2NSD2 | |
| SCHEMBL2782525 | 0.82 | GNG2 (0.70) | GNG2GNB1KDM4AUSP2NSD2 | |
| SCHEMBL13320794 | 0.82 | GNG2 (0.69) | GNG2GNB1KDM4AUSP2NSD2 | |
| SCHEMBL2848097 | 0.80 | GNG2 (0.80) | GNG2GNB1KDM4AUSP2NSD2 | |
| SCHEMBL2777698 | 0.79 | GNG2 (0.69) | GNG2GNB1KDM4AUSP2NSD2 | |
| SCHEMBL13352283 | 0.76 | GNG2 (0.71) | GNG2GNB1KDM4AUSP2NSD2 | |
| SCHEMBL7820781 | 0.76 | GNG2 (0.59) | GNG2GNB1KDM4AUSP2NSD2 | |
| SCHEMBL2840949 | 0.76 | GNG2 (0.64) | GNG2GNB1KDM4AUSP2NSD2 | |
| SCHEMBL2848109 | 0.75 | GNG2 (0.65) | GNG2GNB1KDM4AUSP2NSD2 | |
| SCHEMBL13891771 | 0.74 | GNG2 (0.61) | GNG2GNB1KDM4AUSP2NSD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100130505-A1 | COMPOSITIONS AND METHODS FOR INHIBITING G PROTEIN SIGNALING | UNIVERSITY OF ROCHESTER (US) | 2010-05-27 | — | — | US | claimed |
| EP-2147310-A2 | COMPOSITIONS AND METHODS FOR INHIBITING G PROTEIN SIGNALING | University of Rochester (US) | 2010-01-27 | — | — | EP | claimed |
| EP-1210108-B1 | USE OF LEPTIN TOGETHER WITH AN INHIBITOR OF VEGF AND/OR AN INHIBITOR OF ANGIOGENESIS FOR THE INHIBITION OF ENDOTHELIAL CELL PROLIFERATION | YEDA RES & DEV (IL) | 2009-11-25 | — | — | EP | claimed |
| WO-2009020677-A9 | COMPOSITIONS AND METHODS FOR INHIBITING G PROTEIN SIGNALING | UNIV ROCHESTER (US) | 2009-04-16 | — | — | WO | claimed |
| WO-2009020677-A2 | COMPOSITIONS AND METHODS FOR INHIBITING G PROTEIN SIGNALING | UNIVERSITY OF ROCHESTER (US) | 2009-02-12 | — | — | WO | claimed |
| EP-1210108-A2 | USE OF LEPTIN IN INHIBITION OF ENDOTHELIAL CELL PROLIFERATION | Yeda Research and Development Co. Ltd. (IL) | 2002-06-05 | — | — | EP | claimed |
| WO-2001018040-A2 | USE OF LEPTIN IN INHIBITION OF ENDOTHELIAL CELL PROLIFERATION | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2001-03-15 | — | — | WO | claimed |
| US-8975259-B2 | Compositions and methods for inhibiting G protein signaling | UNIVERSITY OF ROCHESTER (US) | 2015-03-10 | — | — | US | disclosed |
| US-8975259-B2 | Compositions and methods for inhibiting G protein signaling | UNIVERSITY OF ROCHESTER (US) | 2015-03-10 | — | — | US | disclosed |
| US-8975259-B2 | Compositions and methods for inhibiting G protein signaling | UNIVERSITY OF ROCHESTER (US) | 2015-03-10 | — | — | US | disclosed |
| US-8748480-B2 | Methods for treating opioid tolerance | UNIVERSITY OF ROCHESTER (US) | 2014-06-10 | — | — | US | disclosed |
| US-8748480-B2 | Methods for treating opioid tolerance | UNIVERSITY OF ROCHESTER (US) | 2014-06-10 | — | — | US | disclosed |
| US-20130116313-A1 | Compositions and Methods for Inhibiting G Protein Signaling | UNIVERSITY OF ROCHESTER (US) | 2013-05-09 | — | — | US | disclosed |
| US-20060094657-A1 | Inhibiting development of microvessels within coronary or peripheral vessel walls for restenosis/atherosclerosis prevention or therapy | CARDIOVASCULAR RESEARCH FOUNDATION | 2006-05-04 | — | — | US | disclosed |
| US-20030191055-A1 | Inhibiting development of microvessels withins coronary or peripheral vessel walls for restenosis/atherosclerosis prevention or therapy | CARDIOVASCULAR RESEARCH FOUNDATION | 2003-10-09 | — | — | US | disclosed |
| EP-1146891-A4 | INHIBITING DEVELOPMENT OF MICROVESSELS WITHIN VASCULAR WALLS | MEDSTAR RES INST (US) | 2002-07-17 | — | — | EP | disclosed |
| EP-1210108-A2 | USE OF LEPTIN IN INHIBITION OF ENDOTHELIAL CELL PROLIFERATION | Yeda Research and Development Co. Ltd. (IL) | 2002-06-05 | — | — | EP | disclosed |
| EP-1146891-A1 | INHIBITING DEVELOPMENT OF MICROVESSELS WITHIN VASCULAR WALLS | Medstar Research Institute (US) | 2001-10-24 | — | — | EP | disclosed |
| WO-2001018040-A2 | USE OF LEPTIN IN INHIBITION OF ENDOTHELIAL CELL PROLIFERATION | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2001-03-15 | — | — | WO | disclosed |
| WO-2000041712-A1 | INHIBITING DEVELOPMENT OF MICROVESSELS WITHIN VASCULAR WALLS | CARDIOVASCULAR RESEARCH FOUNDATION (US) | 2000-07-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130116313-A1 | Compositions and Methods for Inhibiting G Protein Signaling | GNAI3, GNAI1, GNAI2 | GNG2 7/4885GNB1 4/4885KDM4A 4720/4885 |
| US-20100130505-A1 | COMPOSITIONS AND METHODS FOR INHIBITING G PROTEIN SIGNALING | GNAI1, GNAI3, GNAI2 | GNG2 5/4885GNB1 4/4885KDM4A 4751/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.